番茄社区

Researchers try to make do with the scant data on advanced PE intervention

Trial shows improved patient satisfaction with no aspiration or excess safety events

Researchers are eyeing catheter-based delivery for people with refractory angina

Adoption approached 60% as recently as 2022

Registry analyses look at which patients may be candidates for transcatheter tricuspid therapies

48-mm Xience stent surprised with low restenosis at 1 year

Longer-term trial results support durable quality-of-life advantage

Randomized trial weighs in with extended follow-up

Tool could hold promise for reducing acute kidney injury risk

Group predisposed to calcification shows double digit rate within 6 months

Study outlines room for improvement

6-month follow-up with investigational device gives support for pivotal trial

SAFE-PAD study update doesn't support excess mortality risk

Registry illuminates trends in success, complications